Axon Medical Systems is an Italian medical-device company founded in Naples in 2018, emerging from the research and development department of ACTA Group. It combines industrial expertise, biomedical engineering and clinical collaboration to turn research into practical technologies, with a focus on minimally invasive procedures, oncology and pain management. Axon works with physicians and hospitals throughout product development, clinical validation and regulatory compliance, designing devices around real clinical workflows, ease of use, safety and reliability.

Its first product, Spinery, is a radiofrequency generator for minimally invasive thermal ablation of vertebral metastatic lesions, intended to help relieve pain and improve patients’ quality of life. The company also offers VV+, a radiopaque, high-viscosity bone cement paired with a dedicated injection system designed for high-pressure delivery. Axon provides research and development, specialist training, on-site adoption support, technical assistance, maintenance and regulatory-compliance support. Its credentials include FDA 510(k) clearance for Spinery, CE marking and ISO 13485 certification; the company also reports MHRA approval for Spinery.